西安蓝晓科技新材料股份有限公司 关于对会计师事务所 2024 年履职情况评估及 履行监督职责情况的报告 根据《公司法》《证券法》《上市公司治理准则》《深圳证券交易所上市公 司自律监管指引第 2 号——创业板上市公司规范运作》和西安蓝晓科技新材料股 份有限公司（以下简称"公司"）《公司章程》、《审计委员会工作细则》等规定 和要求，董事会审计委员会本着勤勉尽责的原则，恪尽职守，认真履职。现将董 事会审计委员会对致同会计师事务所（特殊普通合伙）（以下简称"致同事务所"） 2024 年度履职情况评估及履行监督职责的情况汇报如下： 一、2024 年年审会计师事务所基本情况 （一）会计师事务所基本情况 截至 2024 年末，致同事务所从业人员近六千人，其中合伙人 239 名，注册 会计师 1,359 名，签署过证券服务业务审计报告的注册会计师超过 400 人。 二、会计师事务所履职情况 按照《审计业务约定书》，遵循《中国注册会计师审计准则》和其他执业规 范，结合公司 2024 年年报工作安排，致同事务所对公司 2024 年度财务报告进行 审计及对 2024 年 12 月 31 日与财务报告相关的内部控制有效性出具审计报告 ...

| 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2025-019 | | --- | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | | 西安蓝晓科技新材料股份有限公司 关于申请银行贷款并提供资产抵（质）押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）于 2025 年 4 月 21 日召开第五届董事会第八次会议、第五届监事会第五次会议，审议通过了 《关于申请银行贷款并提供资产抵（质）押的议案》。现将具体情况公告如 下： 一、资产抵押基本情况 为满足公司业务发展需要，公司拟以部分土地及地面附属物、外币存单等 资产作为抵（质）押担保标的向银行申请贷款，其中土地、房产等无形资产、 固定资产及投资性房地产等资产账面价值合计不超过 2 亿元,美元存单金额不超 过 5000 万美元。用于抵押、质押的资产及单笔银行贷款金额不超过 1.6 亿元， 最近 12 个月内用于抵押、质押的资产及银行累计贷款额度不超过 10 亿元，在 上述期限和董事会批准的额度权限内可多次 ...

| 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2025-021 | | --- | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | | 西安蓝晓科技新材料股份有限公司 关于召开 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 根据《中华人民共和国公司法》《公司章程》的有关规定，经西安蓝晓科技新材 料股份有限公司（以下简称"公司"）第五届董事会第八次会议审议通过，决定于 2025 年 5 月 19 日（星期一）召开公司 2024 年年度股东大会，现将本次会议有关事项公告 如下： 一、召开会议的基本情况 1.股东大会届次：2024 年年度股东大会。 2.股东大会的召集人：公司董事会。 3.会议召开的合法、合规性：经公司第五届董事会第八次会议审议通过，决定召 开 2024 年年度股东大会，召集程序符合有关法律、行政法规、部门规章、规范性文件 和公司章程的规定。 4.会议召开的日期、时间： （1）现场会议的召开时间：2025 年 5 月 19 日（星期一）下午 14:00。 （2） ...

西安蓝晓科技新材料股份有限公司 监事会对公司 2024 年度内部控制 自我评价报告的核查意见 西安蓝晓科技新材料股份有限公司监事会 2025 年 4 月 23 日 根据《中华人民共和国公司法》（以下简称《公司法》）《企业内部控制基 本规范》及其配套指引的规定和其他内部控制监管要求，结合西安蓝晓科技新材 料股份有限公司（以下简称"公司"）内部控制制度，在内部控制日常监督和专项 监督的基础上，公司董事会对公司截至 2024 年 12 月 31 日的内部控制有效性进 行了评价，并出具了《西安蓝晓科技新材料股份有限公司 2024 年度内部控制自 我评价报告》。公司监事会审阅了公司内部控制自我评价报告，现发表意见如下： 2024 年度，公司根据《公司法》《中华人民共和国证券法》中国证监会以及 深圳证券交易所的相关法律法规要求，结合公司实际情况，建立了较为完善的内 部控制体系，并得到了有效执行。内部控制体系的建立与有效执行保证了公司各 项业务活动的有序、高效开展，起到了较好的风险防范和控制作用，确保了公司 资产的安全、完整，维护了公司及全体股东的利益。公司编制的《西安蓝晓科技 新材料股份有限公司 2024 年度内部控制自 ...

| 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2025-012 | | --- | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | | 西安蓝晓科技新材料股份有限公司 第五届监事会第五次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"或"蓝晓科技"）第五届 监事会第五次会议通知和议案等材料已于 2025 年 4 月 11 日以电子邮件、书面送 达等方式发送至各位监事，并于 2025 年 4 月 21 日在公司会议室召开会议。本次 会议应出席监事 3 人，实际到会 3 人，公司部分高级管理人员参加了会议。会议 由监事会主席李延军先生主持。会议符合《中华人民共和国公司法》（以下简称 《公司法》）及《公司章程》的有关规定。会议审议通过了如下决议： 一、审议通过《2024 年度监事会工作报告》 表决情况：3 票赞成，0 票弃权，0 票反对。本议案获表决通过。 本议案尚需提交 2024 年年度股东大会审议。 《2024 年度监事会工作报告》详见巨潮资讯网 ...

Financial Performance - Xi'an Blue Sky Technology achieved operating revenue of 2.55 billion yuan and a net profit attributable to shareholders of 787 million yuan in 2024[6]. - The basic operating revenue, excluding the lithium extraction project, was 2.45 billion yuan, representing a year-on-year growth of 24.7%[6]. - Operating cash flow net amount reached 730 million yuan, an increase of 9.3% year-on-year[6]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the fiscal year, representing a 25% year-over-year growth[24]. - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 20% to 1.44 billion RMB[24]. - The company's operating revenue for 2024 reached ¥2,554,030,243.10, representing a 2.62% increase compared to ¥2,488,817,821.21 in 2023[29]. - Net profit attributable to shareholders for 2024 was ¥787,240,240.66, a 9.79% increase from ¥717,032,641.13 in 2023[29]. - The net profit after deducting non-recurring gains and losses was ¥745,023,656.96, up 2.99% from ¥723,426,143.47 in 2023[29]. - The company's total assets increased by 6.85% to ¥6,085,140,907.36 at the end of 2024, compared to ¥5,695,042,410.99 at the end of 2023[29]. - The net assets attributable to shareholders rose by 13.89% to ¥3,914,646,637.73 at the end of 2024, up from ¥3,437,103,511.00 at the end of 2023[29]. - The basic earnings per share for 2024 was ¥1.56, reflecting a 9.09% increase from ¥1.43 in 2023[29]. - The company reported a net cash flow from operating activities of ¥731,847,446.44, which is a 9.34% increase from ¥669,316,289.82 in 2023[29]. Market Expansion and Strategy - The overseas sales revenue reached a new high, with continuous expansion of the localized marketing network and an increase in foreign employee numbers[7]. - The company aims to enhance its global supply chain and financial security by building overseas production capacity and logistics channels[8]. - The company is expanding its market presence in Southeast Asia, targeting a 15% market share by 2025[24]. - A strategic acquisition of a local competitor is in progress, which is anticipated to increase production capacity by 40%[24]. - The company is actively pursuing international expansion and has rapidly increased its market share, benefiting from changes in the industry landscape[47]. - The company has established a global marketing and technical service network, expanding its presence in North America and Europe to enhance its international influence[110]. - The company is committed to advancing its international strategy, enhancing its overseas operational capabilities, and expanding its overseas sales network[172]. Research and Development - The company is investing 100 million RMB in R&D for new technologies in adsorption materials over the next two years[24]. - The R&D team consists of nearly 400 members with extensive experience, focusing on various fields including polymer materials and biomedicine[93]. - The company has developed multiple proprietary technologies for the synthesis of adsorption materials, enhancing its competitive edge in various applications[87]. - The company has established partnerships with three major universities for collaborative research on new materials[24]. - The company is actively promoting the innovation of adsorption separation technology in metals such as cobalt, nickel, and vanadium, as well as in biopharmaceuticals[84]. - The company has made significant advancements in the fields of metal resource extraction and life sciences, contributing to the technological progress and quality improvement in downstream industries[100]. Product Development and Innovation - New product development includes the launch of a series of advanced ion exchange resins, expected to enhance market competitiveness[24]. - The solid-phase synthesis carrier for GLP-1 weight loss drugs saw a significant increase in orders, positioning the company as a key supplier in the market[6]. - The company has developed advanced technologies in the field of super-pure water, breaking the monopoly of a few foreign companies[57]. - The company has achieved significant breakthroughs in basic technology research, leading to the industrialization of original technologies in emerging application fields[53]. - The company has developed a comprehensive solution model combining material manufacturing, application processes, and system devices, which has gained recognition in the industry[98]. Environmental and Social Governance (ESG) - The company emphasizes the importance of ESG principles, focusing on green and low-carbon development in its operations[9]. - The company integrates ESG principles into its operations, aiming to create a "green factory" and enhance transparency in information disclosure[174]. - The environmental pressure has accelerated the development of the adsorption separation materials industry, with increasing demand for materials that can effectively address air and water pollution[45]. Financial Management and Investments - The company plans to distribute a cash dividend of 6.00 yuan per 10 shares (including tax) to all shareholders[12]. - The company has established a market value management system to enhance investor returns and protect their interests, as approved in the board meeting on December 30, 2024[186]. - The company is committed to providing stable cash dividends to shareholders while aligning with its operational and business development goals[188]. - The company has committed to various projects funded by the raised capital, with specific progress and feasibility assessments ongoing[159]. Production Capacity and Operations - The company has increased its production capacity from less than 10,000 tons to 50,000 tons with the establishment of two high-quality production bases in 2020[49]. - The designed capacity for adsorption separation materials is 50,000 tons per annum, with a utilization rate of 131.42%[88]. - The company is planning to build an additional 20,000 tons per annum capacity for adsorption separation materials at its wholly-owned subsidiary, Pucheng Lanxiao, which is currently in the land use rights acquisition stage[88]. - The company has completed and is executing lithium extraction projects with a total capacity of nearly 100,000 tons of lithium carbonate/hydroxide[70]. Risk Management - The company acknowledges increased market competition and intends to strengthen R&D investment to maintain its competitive edge[176]. - The company is implementing measures to manage accounts receivable risks as customer bases and order volumes grow[177]. - The company is actively managing risks associated with the globalization of its operations, ensuring compliance with international regulations and policies[181]. - The company aims to mitigate foreign exchange risks through hedging strategies, emphasizing the importance of real-time market analysis and adjustments to strategies[155]. Corporate Governance - The company has a comprehensive internal governance structure that complies with relevant laws and regulations, ensuring transparency and protecting investor rights[190]. - The board of directors consists of 9 members, including 3 independent directors, and operates under various specialized committees[193]. - The supervisory board is composed of 3 supervisors, including 1 employee representative, ensuring compliance with legal and regulatory requirements[194]. - The company maintains complete independence from the controlling shareholder in terms of business, personnel, assets, and finance[198].

Revenue and Profitability - The company's revenue for Q1 2025 was ¥576,792,352.46, a decrease of 8.58% compared to ¥630,918,111.12 in the same period last year[6] - Net profit attributable to shareholders increased by 14.18% to ¥193,136,181.95 from ¥169,143,949.73 year-on-year[6] - Total operating revenue decreased to ¥576,792,352.46 from ¥630,918,111.12, representing a decline of approximately 8.6% year-over-year[21] - Net profit increased to ¥195,524,270.68 from ¥171,070,494.43, reflecting a growth of approximately 14.3% year-over-year[22] - Basic earnings per share rose by 11.76% to ¥0.38, compared to ¥0.34 in the same period last year[6] - Earnings per share (basic) rose to ¥0.38 from ¥0.34, indicating an increase of about 11.8% year-over-year[23] Cash Flow and Financial Position - The net cash flow from operating activities surged by 101.81% to ¥146,514,402.56, up from ¥72,599,287.10 in the previous year[10] - Cash flow from operating activities increased to ¥489,681,223.73 from ¥477,849,001.70, showing a growth of approximately 2.7% year-over-year[25] - Total cash and cash equivalents at the end of the period reached $2,395,635,334.36, up from $1,756,901,062.14, reflecting a net increase of $143,819,629.43[27] - The net cash flow from financing activities improved to $2,589,721.53 from a negative $24,954,866.11, showing a recovery in financing operations[26] - Cash outflows for operating activities totaled $343,166,821.17, a decrease from $405,249,714.60, reflecting cost management efforts[26] Assets and Liabilities - Total assets increased by 3.14% to ¥6,276,193,800.69 from ¥6,085,140,907.36 at the end of the previous year[6] - Total liabilities decreased to ¥2,143,231,753.10 from ¥2,158,316,086.51, a reduction of about 0.7% year-over-year[19] - The company's equity attributable to shareholders grew by 5.20% to ¥4,118,395,775.74 from ¥3,914,646,637.73 at the end of the last year[6] - The company's total equity increased to ¥4,132,962,047.59 from ¥3,926,824,820.85, representing a growth of about 5.2% year-over-year[19] Investment and Expenses - Investment income increased significantly by 937.57% to ¥3,086,808.72 from a loss of ¥368,544.31 in the previous year[9] - Research and development expenses decreased to ¥32,910,445.02 from ¥39,146,377.46, a decline of about 16.0% year-over-year[22] - The company received $80,000,000.00 from investment recoveries, up from $46,000,000.00, highlighting improved asset management[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 21,799[12] - The largest shareholder, Mr. Kou Xiaokang, holds 24.38% of shares, totaling 123,743,485 shares, with 12,110,000 shares pledged[12] - The top ten shareholders collectively hold significant stakes, with the top four shareholders alone accounting for over 57% of the total shares[12] Legal Matters - The company is involved in ongoing litigation regarding a compensation claim of ¥53.5 million related to an incident involving Inner Mongolia Tongwei High Purity Crystalline Silicon Co., Ltd.[14] - The company has initiated legal action against San Da Membrane Environmental Technology Co., Ltd. for unpaid contract amounts, with a counterclaim for breach of contract amounting to ¥17.556 million[14] Other Financial Metrics - The company reported a 35.66% increase in income tax expenses, amounting to ¥34,531,325.73 compared to ¥25,454,733.71 last year, due to increased profits[9] - The company experienced a 339.27% increase in the impact of exchange rate changes on cash and cash equivalents, amounting to ¥6,049,151.14[10] - The company paid $89,335,851.98 in employee compensation, an increase from $77,019,376.10, indicating a rise in workforce costs[26] - The impact of exchange rate changes on cash and cash equivalents was a positive $6,049,151.14, contrasting with a negative impact of $2,528,126.60 in the previous period[26] - The first quarter report was not audited, which may affect the reliability of the financial data presented[28]

西安蓝晓科技新材料股份有限公司 第五届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"或"蓝晓科技"）第五 届董事会第八次会议通知和议案等材料已于 2025 年 4 月 11 日以电子邮件、书 面送达等方式发送至各位董事，并于2025年4月21日在公司会议室召开会议。 本次会议应出席董事 9 人，实际到会 9 人，公司部分监事和相关人员参加了会 议。会议由董事长高月静女士主持。会议符合《中华人民共和国公司法》（以 下简称《公司法》）及《公司章程》的有关规定。会议审议通过了如下决议： 一、审议通过《2024 年度总经理工作报告》 董事会听取了公司总经理所做的《2024 年度总经理工作报告》，认为 2024 年度公司管理层有效执行了董事会以及股东大会的各项决议，完成了 2024 年 度的经营目标。 | 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2025-011 | | --- | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | | 表决 ...

| 证券代码：300487 | 证券简称：蓝晓科技 | | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | | | 公告编号：2025-010 | 西安蓝晓科技新材料股份有限公司 关于"蓝晓转 02"2025 年付息公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1. 蓝晓转 02（债券代码：123195）将于 2025 年 4 月 17 日按面值支付第二 年利息，每 10 张蓝晓转 02（面值 1,000 元）利息为 6.00 元（含税）。 2. 债权登记日：2025 年 4 月 16 日。 3. 本次付息期间及票面利率：计息期间为 2024 年 4 月 17 日至 2025 年 4 月 16 日，票面利率为 0.60%。 4. 付息日：2025 年 4 月 17 日。 5. 除息日：2025 年 4 月 17 日。 6. "蓝晓转 02"本次付息的债权登记日为 2025 年 4 月 16 日，截至 2025 年 4 月 16 日下午深圳证券交易所收市后，在中国证券登记结算有限责任公司深 圳分公司（以下简 ...

| 证券代码：300487 | 证券简称：蓝晓科技 公告编号：2025-009 | | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转02 | 注：高月静女士、寇晓康先生、田晓军先生累计质押限售股份性质为高管锁定股。 备查文件 中国证券登记结算有限责任公司出具的《证券质押及司法冻结明细表》。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）接到公司控股股东高 月静女士、寇晓康先生，持股股东田晓军先生的通知，高月静女士、寇晓康先生、 田晓军先生于近日办理了其持有的部分股份解除质押业务，现将有关情况公告如 下： 二、股东股份累计被质押情况 截止本公告披露日，上述股东所持质押股份情况如下： 股东 名称 是否为 第一大 股东及 一致行 动人 本次解除 质押股份 数量 （万股） 占其 所持 股份 比例 占公司 总股本 比例 起始日 解除日 质权人 高月静 是 220 3.36% 0.43% 2024.3.28 2025.4.7 中原信托有限公司 108 1.65% 0.21% 2024.3.29 2025.4.7 云南国际信托有限 公司 寇晓康 是 630 5.09% 1.24% 2024. ...